FENC analyst estimates
Fennec Pharmaceuticals (FENC) analyst ratings, the average price target and its range, and every firm's latest call.
FENC analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Aug 12, 2026 | Wedbush | Fennec price target raised to $16 from $13 at Wedbush | $16.00 |
| May 22, 2026 | H.C. Wainwright | Fennec price target raised to $16 from $13 at H.C. Wainwright | $16.00 |
| Jan 8, 2026 | Piper Sandler | Fennec initiated with an Overweight at Piper Sandler | $18.00 |
| Aug 15, 2025 | Craig-Hallum | Fennec price target raised to $14 from $13 at Craig-Hallum | $14.00 |
| May 15, 2024 | H.C. Wainwright | Fennec Pharmaceuticals Inc. (FENC) PT Lowered to $15 at H.C. Wainwright | $15.00 |
| May 15, 2024 | Craig-Hallum | Fennec price target lowered to $17 from $20 at Craig-Hallum | $17.00 |
| Apr 4, 2024 | H.C. Wainwright | Fennec price target raised to $18 from $17 at H.C. Wainwright | $18.00 |
| Mar 19, 2024 | Craig-Hallum | Fennec Pharmaceuticals Inc. (FENC) PT Raised to $18 at Craig-Hallum | $18.00 |
| Nov 22, 2022 | Cantor Fitzgerald | Cantor Fitzgerald Upgrades Fennec Pharmaceuticals to Overweight, Raises Price Target to $12 | $12.00 |
| Sep 26, 2022 | Wedbush | Wedbush Maintains Outperform on Fennec Pharmaceuticals, Raises Price Target to $19 | $19.00 |
- 3 firms rate FENC: 3 buy, 0 hold, 0 sell.
- The average price target is $17.00 from None analysts, from $16.00 to $19.00.
Updated 2026-11-17 17:46 UTC